These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34624627)

  • 41. Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver.
    Kitamura S; Nitta K; Tayama Y; Tanoue C; Sugihara K; Inoue T; Horie T; Ohta S
    Drug Metab Dispos; 2008 Jul; 36(7):1202-5. PubMed ID: 18332084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
    Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
    J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
    Adusumalli S; Jamwal R; Obach RS; Ryder TF; Leggio L; Akhlaghi F
    Drug Metab Dispos; 2019 Aug; 47(8):874-882. PubMed ID: 31182423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy.
    Sanoh S; Tayama Y; Sugihara K; Kitamura S; Ohta S
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):52-63. PubMed ID: 25760530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictability of human pharmacokinetics of diisononyl phthalate (DINP) using chimeric mice with humanized liver.
    Iwata H; Goto M; Sakai N; Suemizu H; Yamazaki H
    Xenobiotica; 2019 Nov; 49(11):1311-1322. PubMed ID: 30589368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different Roles of Human Cytochrome P450 2C9 and 3A Enzymes in Diclofenac 4'- and 5-Hydroxylations Mediated by Metabolically Inactivated Human Hepatocytes in Previously Transplanted Chimeric Mice.
    Miura T; Uehara S; Shimizu M; Murayama N; Utoh M; Suemizu H; Yamazaki H
    Chem Res Toxicol; 2020 Feb; 33(2):634-639. PubMed ID: 31854189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic variants of aldehyde oxidase (AOX) 1 in cynomolgus and rhesus macaques.
    Uno Y; Uehara S; Murayama N; Yamazaki H
    Xenobiotica; 2021 Apr; 51(4):494-499. PubMed ID: 33434089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
    Kitamura S; Sugihara K
    Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes.
    Suemizu H; Sota S; Kuronuma M; Shimizu M; Yamazaki H
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):468-73. PubMed ID: 25158275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of plasma protein binding in two mouse models of humanized liver, PXB mouse and humanized TK-NOG mouse.
    Miyamoto M; Kosugi Y; Iwasaki S; Chisaki I; Nakagawa S; Amano N; Hirabayashi H
    Xenobiotica; 2021 Jan; 51(1):51-60. PubMed ID: 32779988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
    Austin NE; Baldwin SJ; Cutler L; Deeks N; Kelly PJ; Nash M; Shardlow CE; Stemp G; Thewlis K; Ayrton A; Jeffrey P
    Xenobiotica; 2001; 31(8-9):677-86. PubMed ID: 11569533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of Extrahepatic Aldehyde Oxidase Activity to Human Clearance.
    Kozminski KD; Selimkhanov J; Heyward S; Zientek MA
    Drug Metab Dispos; 2021 Sep; 49(9):743-749. PubMed ID: 34162687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development.
    Gajula SNR; Nathani TN; Patil RM; Talari S; Sonti R
    Drug Metab Rev; 2022 Nov; 54(4):427-448. PubMed ID: 36369949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Aldehyde Oxidase in the Metabolic Clearance of Substituted Benzothiazoles.
    Teffera Y; Liu J; Krolikowski P; Zhao Z
    Drug Metab Lett; 2021; 14(2):126-136. PubMed ID: 34818997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of minipig, dog, monkey and human drug metabolism and disposition.
    Dalgaard L
    J Pharmacol Toxicol Methods; 2015; 74():80-92. PubMed ID: 25545337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism and pharmacokinetics characterization of metarrestin in multiple species.
    Padilha EC; Shah P; Wang AQ; Singleton MD; Hughes EA; Li D; Rice KA; Konrath KM; Patnaik S; Marugan J; Rudloff U; Xu X
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):805-816. PubMed ID: 32185484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
    Klecker RW; Cysyk RL; Collins JM
    Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. o-Toluidine metabolism and effects in the urinary bladder of humanized-liver mice.
    Yokota Y; Suzuki S; Gi M; Yanagiba Y; Yoneda N; Fujioka M; Kakehashi A; Koda S; Suemizu H; Wanibuchi H
    Toxicology; 2023 Apr; 488():153483. PubMed ID: 36870411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic profiles of pomalidomide in human plasma simulated with pharmacokinetic data in control and humanized-liver mice.
    Shimizu M; Suemizu H; Mitsui M; Shibata N; Guengerich FP; Yamazaki H
    Xenobiotica; 2017 Oct; 47(10):844-848. PubMed ID: 27852146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.